Biogen shares are trading higher after the company issued Q2 in-process research and development guidance.
Biogen shares are trading higher after the company issued Q2 in-process research and development guidance.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.